06.29.10
Teva Pharmaceutical Industries, Ltd. received approval from the FDA for Venlafaxine HCl ER Capsules, the company’s generic version of Wyeth’s antidepressant Effexor XR. The generic drug is expected to ship on July 1, 2010, in accordance with the 2006 agreement with Wyeth.
Teva is the first company to file an aNDA containing a paragraph IV certification for this product and has been awarded a 180-day period of marketing exclusivity. Effexor had $2.7 billion in sales in the U.S. in 2009.
Teva is the first company to file an aNDA containing a paragraph IV certification for this product and has been awarded a 180-day period of marketing exclusivity. Effexor had $2.7 billion in sales in the U.S. in 2009.